Consumer Driven Health Care

"The debate around GLP-1 coverage is a prime example of the balancing act benefits leaders face as they navigate skyrocketing demand, affordability concerns and uncertainty around long-term patient outcomes," said Morgan Lee, vice president of research and marketing at Pharmaceutical Strategies Group.